Clinical Trial Update: Nasal Administration of Dexamethasone for Multiple Sclerosis (MS) Treatment [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating nasal dexamethasone for multiple sclerosis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: MS Patient With Relpasing Remitting Attacks | Phase 1 | Status: WITHDRAWN